Stocks making the biggest premarket moves: Kraft Heinz, PepsiCo, Biogen, Signet Jewelers and more

Premarket trading highlighted significant corporate developments and financial performance, with PepsiCo rising nearly 6% on reports of a $4 billion activist stake by Elliott Management and Kraft Heinz confirming its split into two public companies. Major M&A activity saw Air Lease gain over 6% following a $28.2 billion merger deal, while biopharmaceutical firm Cytokinetics soared 27% on positive clinical trial results for its heart disease drug. Elsewhere, Signet Jewelers advanced on better-than-expected earnings and raised guidance, contrasting with Lam Research's 3.7% decline after a Morgan Stanley downgrade citing future growth concerns.

Analysis

Premarket activity is being driven by a confluence of distinct, company-specific catalysts, including M&A, activist intervention, and fundamental performance updates. In the M&A and corporate strategy space, Air Lease shares surged over 6% on a definitive merger agreement valuing the company at approximately $28.2 billion, while PepsiCo rose nearly 6% on reports that activist investor Elliott Management has acquired a $4 billion stake, signaling potential for strategic changes. Conversely, Kraft Heinz's confirmation of a tax-free spinoff into two separate public entities was met with a muted market reaction, suggesting the move was either priced in or its value creation is viewed as uncertain. Strong earnings fundamentals were a key driver for Signet Jewelers, which climbed 3.8% after beating Q2 consensus estimates with an EPS of $1.61 versus $1.24 expected and raising its full-year guidance. The biotechnology sector saw significant movement, with Cytokinetics soaring 27% on positive clinical trial data for its heart disease drug, a major de-risking event. Divergent analyst calls created volatility in the technology sector; Lam Research fell 3.7% following a Morgan Stanley downgrade citing concerns over growth sustainability into 2026, whereas Corning gained 1.3% on a UBS upgrade linked to AI-driven growth. Lastly, Nio presented a mixed signal, gaining 1.5% on record August deliveries but simultaneously reporting disappointing quarterly earnings and revenue.

Key Decisions for Investors

• Investors should monitor PepsiCo for potential value-unlocking initiatives following the reported activist stake, while the Air Lease merger at a ~$28.2 billion valuation offers a clear arbitrage or exit opportunity ahead of its expected close next year.
• The 27% surge in Cytokinetics on positive trial data warrants a reassessment of the company's valuation based on the drug's commercial potential, representing a more significant catalyst than Biogen's incremental gain from an improved drug delivery method.
• The conflicting analyst actions on Lam Research and Corning highlight the need for selectivity in tech hardware; positions should be evaluated based on exposure to long-term cyclical risks versus near-term secular tailwinds like AI.
• For Nio, the disconnect between record operational deliveries and disappointing financial results requires careful scrutiny, as the market's modest reaction indicates uncertainty regarding its path to profitability.
• Signet Jewelers' strong earnings beat and raised guidance may signal underrated strength in specific consumer discretionary segments, prompting a review of holdings in the specialty retail space for similar fundamental outperformance.